The Latest Headlines at American Banking and Market News
Check Point Software Technologies (NASDAQ:CHKP) Stock Rating Reaffirmed by Wedbush
Check Point Software Technologies (NASDAQ:CHKP – Get Free Report)‘s stock had its “outperform” rating reaffirmed by research analysts at Wedbush in a research note issued on Friday, Benzinga reports. They presently... More of this article »
Blueprint Medicines (NASDAQ:BPMC) PT Raised to $130.00
Blueprint Medicines (NASDAQ:BPMC – Get Free Report) had its price target boosted by research analysts at Stifel Nicolaus from $120.00 to $130.00 in a note issued to investors on Friday, Benzinga reports. The brokerage presently... More of this article »
Keefe, Bruyette & Woods Lowers Brookline Bancorp (NASDAQ:BRKL) Price Target to $10.50
Brookline Bancorp (NASDAQ:BRKL – Get Free Report) had its price target reduced by Keefe, Bruyette & Woods from $12.00 to $10.50 in a note issued to investors on Friday, Benzinga reports. The firm currently has a “market... More of this article »
Needham & Company LLC Reiterates “Buy” Rating for Blueprint Medicines (NASDAQ:BPMC)
Blueprint Medicines (NASDAQ:BPMC – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at Needham & Company LLC in a report released on Friday, Benzinga reports. They currently... More of this article »
Check Point Software Technologies (NASDAQ:CHKP) PT Lowered to $165.00
Check Point Software Technologies (NASDAQ:CHKP – Get Free Report) had its price target cut by analysts at Stifel Nicolaus from $170.00 to $165.00 in a research note issued on Friday, Benzinga reports. The firm currently has... More of this article »
Barclays Increases Check Point Software Technologies (NASDAQ:CHKP) Price Target to $175.00
Check Point Software Technologies (NASDAQ:CHKP – Get Free Report) had its target price boosted by research analysts at Barclays from $170.00 to $175.00 in a report released on Friday, Benzinga reports. The firm currently has... More of this article »
Wedbush Reiterates “Outperform” Rating for Blueprint Medicines (NASDAQ:BPMC)
Blueprint Medicines (NASDAQ:BPMC – Get Free Report)‘s stock had its “outperform” rating reiterated by Wedbush in a research report issued to clients and investors on Friday, Benzinga reports. They presently... More of this article »
GE HealthCare Technologies Inc. (NASDAQ:GEHC) Given Average Recommendation of “Moderate Buy” by Analysts
Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Get Free Report) have earned an average rating of “Moderate Buy” from the eleven brokerages that are presently covering the firm, Marketbeat Ratings reports.... More of this article »
Check Point Software Technologies (NASDAQ:CHKP) Stock Rating Reaffirmed by Needham & Company LLC
Check Point Software Technologies (NASDAQ:CHKP – Get Free Report)‘s stock had its “hold” rating reaffirmed by stock analysts at Needham & Company LLC in a research report issued on Friday, Benzinga reports. Several... More of this article »
Blueprint Medicines (NASDAQ:BPMC) Stock Rating Reaffirmed by HC Wainwright
Blueprint Medicines (NASDAQ:BPMC – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a note issued to investors on Friday, Benzinga reports. They currently have... More of this article »
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are covering the stock, MarketBeat Ratings reports. Two analysts... More of this article »
Marriott International, Inc. (NASDAQ:MAR) Receives Average Recommendation of “Hold” from Brokerages
Shares of Marriott International, Inc. (NASDAQ:MAR – Get Free Report) have been given an average rating of “Hold” by the fifteen research firms that are presently covering the company, MarketBeat.com reports. Ten... More of this article »
Synaptics Incorporated (NASDAQ:SYNA) Receives Consensus Rating of “Moderate Buy” from Brokerages
Shares of Synaptics Incorporated (NASDAQ:SYNA – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the nine research firms that are presently covering the firm, MarketBeat.com reports.... More of this article »